Alzheimer’s Therapeutics Market Poised for Explosive Growth at 9.2% CAGR, Reaching US$7.4 Billion by 2033 | FMI

Posted on 2024-06-10 by Future Market Insights in Healthcare, Pharmaceuticals // 0 Comments

Alzheimer’s Therapeutics Market

The Alzheimer’s Therapeutics Market is experiencing a surge in momentum, fueled by the urgent need for effective treatments to combat this devastating disease. According to industry estimates, the market held a valuation of US$3,052.3 million in 2023. A robust projection anticipates a Compound Annual Growth Rate (CAGR) of 9.2%, leading the market to reach a staggering US$7,359.7 million by 2033. This significant growth underscores the growing importance of effective Alzheimer’s therapies and reflects a dual focus: the rising prevalence of the disease and the unwavering commitment to finding solutions that alleviate its impact on patients and healthcare systems worldwide.

Population aging across the globe is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in the number of the aged population. In addition, is associated with an increased prevalence of chronic diseases like dementia.

Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14497

Therapies for alzheimer’s therapeutics offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease Alzheimer’s Therapeutics cement. Thus, the magnitude of the affected population and the lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers.

However, the identification of the primary reasons and mechanisms involved in Alzheimer’s therapeutics is limited. Drug manufacturers have been unable to validate the significant clinical benefits of treatment for numerous new compounds due to strict regulations. One of the significant trends observed in this market is the collaboration of the existing players.

Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates, which is further expected to propel the demand.

Developing countries are expected to offer lucrative opportunities for this market. According to Alzheimer’s Therapeutics International in 2015, 58% of people with dementia live in developing countries, but by 2050 this will rise to 68%. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific region.

According to World Alzheimer Report in 2015, regional estimations of dementia prevalence in people aged 60 years and over vary from 4.6% in Central Europe to 8.7% in North Africa and the Middle East, however, all other regional estimates fall in a relatively between 5.6% and 7.6%.

A list of Key Players Covered in the Alzheimer’s Therapeutics Market are:

AbbVie, Inc.
Teva Pharmaceuticals Ltd.
Eisai Co., Ltd.
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Novartis AG
Zydus Lifesciences Ltd (CADILA)
Sun Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories Ltd
Aurobindo Pharma Ltd
Amneal Pharmaceuticals Inc.
Macleods Pharmaceuticals Ltd.
Viatris Inc.
Lupin Ltd
Cipla Ltd.
Torrent pharmaceuticals ltd.
Unichem laboratories ltd
Lannett Inc.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/14497

Key Segments Covered in Alzheimer’s Therapeutics Market Research

By Drug Name:

Donepezil
Rivastigmine
Memantine
Galantamine
Manufactured a combination of memantine and donepezil

By Drug Class:

Cholinesterase Inhibitors
NMDA Receptor Antagonists
Manufactured Combination

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick